scholarly article | Q13442814 |
P356 | DOI | 10.1111/ECI.12471 |
P698 | PubMed publication ID | 26036750 |
P50 | author | Cristian Martignani | Q117250289 |
Alessandro Corzani | Q117250310 | ||
Gianmario Sambuceti | Q42880617 | ||
Igor Diemberger | Q45909980 | ||
Giuseppe Boriani | Q56454942 | ||
Stefano Fanti | Q60369734 | ||
Matteo Ziacchi | Q88003290 | ||
Mauro Biffi | Q89208501 | ||
Cristina Nanni | Q91856665 | ||
P2093 | author name string | Stefano Boschi | |
P2860 | cites work | Norepinephrine transporter function and human cardiovascular disease | Q33161828 |
ACC/AHA/ACR/ASE/ASNC/HRS/NASCI/RSNA/SAIP/SCAI/SCCT/SCMR/SIR 2008 Key Data Elements and Definitions for Cardiac Imaging A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee | Q33396887 | ||
A catalogue of reporting guidelines for health research | Q34091472 | ||
Evidence for regional catecholamine uptake and storage sites in the transplanted human heart by positron emission tomography | Q34188430 | ||
Enhanced Galphaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure | Q36286936 | ||
Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice. | Q36391033 | ||
Molecular imaging in heart failure patients | Q42345701 | ||
Cardiotoxic and cardioprotective features of chronic β-adrenergic signaling | Q43131986 | ||
Cardiac resynchronization induces favorable neurohumoral changes | Q46434476 | ||
Cardiac sympathetic activity pre and post resynchronization therapy evaluated by 123I-MIBG myocardial scintigraphy | Q46894186 | ||
Interventricular delay interval optimization in cardiac resynchronization therapy guided by echocardiography versus guided by electrocardiographic QRS interval width. | Q47245973 | ||
Improvement in cardiac sympathetic nerve activity in responders to resynchronization therapy | Q47879533 | ||
Left ventricular versus biventricular pacing: a randomized comparative study evaluating mid-term electromechanical and clinical effects. | Q47917914 | ||
Neurohormones and inflammatory mediators in patients with heart failure undergoing cardiac resynchronization therapy: time courses and prediction of response | Q48580668 | ||
Association of cardiac autonomic neuropathy with subclinical myocardial dysfunction in type 2 diabetes. | Q54017801 | ||
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities | Q58972654 | ||
P433 | issue | 8 | |
P921 | main subject | cardiology | Q10379 |
P304 | page(s) | 792-799 | |
P577 | publication date | 2015-07-03 | |
P1433 | published in | European Journal of Clinical Investigation | Q15745208 |
P1476 | title | Cardiac resynchronization therapy and cardiac sympathetic function | |
P478 | volume | 45 |
Q49659648 | Cardiac Innervation and the Autonomic Nervous System in Sudden Cardiac Death |
Q92378330 | Molecular Imaging of the Heart |
Q43114661 | Pathophysiology of dyssynchrony: of squirrels and broken bones |
Q38742559 | Recent Advances and Clinical Applications of PET Cardiac Autonomic Nervous System Imaging |
Q92616691 | The molecular basis for the neutral effect of renal denervation in patients with chronic heart failure not responding to cardiac resynchronisation therapy - a perspective |